Key result
Maternal KCNQ1 p.Val173Asp variant impairs IKs channel function and shifts activation voltage by ~10 mV.
Why the study?
Recurrent pregnancy loss affects 1% to 2% of couples, and a large fraction remains idiopathic, warranting research into monogenic causes.
Does the maternal KCNQ1 p.Val173Asp variant cause IKs channel dysfunction and predispose to idiopathic recurrent pregnancy loss?
Case Report (n=1)
Does the maternal KCNQ1 p.Val173Asp variant cause IKs channel dysfunction and predispose to idiopathic recurrent pregnancy loss?
Concealed maternal type 1 long-QT syndrome caused by a loss-of-function KCNQ1 p.Val173Asp variant is a potential novel monogenic cause of unexplained recurrent pregnancy loss and fetal death, warranting family cascade screening and arrhythmia prevention.
Answers are grounded in this paper and cite their sources.
Supports concealed maternal LQTS as potential cause of recurrent fetal loss; hypothesis-generating, prospective studies needed before screening.
Background Recurrent pregnancy loss affects 1% to 2% of couples attempting childbirth. A large fraction of all cases remains idiopathic, which warrants research into monogenic causes of this distressing disorder. Methods and Results We investigated a nonconsanguineous Estonian family who had experienced 5 live births, intersected by 3 early pregnancy losses, and 6 fetal deaths, 3 of which occurred during the second trimester. No fetal malformations were described at the autopsies performed in 3 of 6 cases of fetal death. Parental and fetal chromosomal abnormalities (including submicroscopic) and maternal risk factors were excluded. Material for genetic testing was available from 4 miscarried cases (gestational weeks 11, 14, 17, and 18). Exome sequencing in 3 pregnancy losses and the mother identified no rare variants explicitly shared by the miscarried conceptuses. However, the mother and 2 pregnancy losses carried a heterozygous nonsynonymous variant, resulting in p.Val173Asp ( rs199472695 ) in the ion channel gene KCNQ1 . It is expressed not only in heart, where mutations cause type 1 long‐QT syndrome, but also in other tissues, including uterus. The p.Val173Asp variant has been previously identified in a patient with type 1 long‐QT syndrome, but not reported in the Genome Aggregation Database. With heterologous expression in CHO cells, our in vitro electrophysiologic studies indicated that the mutant slowly activating voltage‐gated K+ channel ( I Ks ) is dysfunctional. It showed reduced total activating and deactivating currents ( P <0.01), with dramatically positive shift of voltage dependence of activation by ≈10 mV ( P <0.05). Conclusions The current study uncovered concealed maternal type 1 long‐QT syndrome as a potential novel cause behind recurrent fetal loss.
No takes yet. Share an insight, caveat, or question.
Kasak et al. (2021) conducted a case report in Recurrent pregnancy loss and concealed type 1 long-QT syndrome (n=1). KCNQ1 p.Val173Asp (c.518T>A) heterozygous missense variant vs. Wild-type KCNQ1 channel coexpressed with wild-type KCNE1 in CHO cells was evaluated on Slowly activating voltage-gated K+ channel (IKs) steady-state activating and deactivating tail current densities and voltage dependence of activation in CHO cells (p=<0.01). The maternal KCNQ1 p.Val173Asp variant linked to recurrent fetal loss reduced IKs activating and deactivating currents and shifted activation voltage by ~10 mV.
Synapse has enriched 10 related papers. Consider them for comparative context: